Accuray Incorporated to Report Second Quarter Fiscal Year 2008 Financial Results

SUNNYVALE, Calif., Dec. 21 /PRNewswire-FirstCall/ -- Accuray Incorporated
(Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced
that it will report results for its second quarter fiscal year 2008, ending
December 29, 2007, on Wednesday, January 30, 2008 after the market closes.
A conference call to review the results will begin at 2:00 p.m. PST
(5:00 p.m. EST) and will be hosted by Euan S. Thomson, Ph.D., president and
chief executive officer and Robert E. McNamara, senior vice president and
chief financial officer.
The conference call dial-in numbers are (866) 288-0541 (USA) or
(913) 312-1268 (International), Access Code: 4129411. In addition, a dial-up
replay of the conference call will be available beginning January 30, 2008 at
5:00 p.m. PST (8:00 p.m. EST) and ending on February 14, 2008. The replay
telephone number is (888) 203-1112 (USA) or (719) 457-0820 (International),
Access Code: 4129411.
A live webcast of the call will also be available from the Investor
Relations section of the corporate Web site at http://www.accuray.com. A
webcast replay can be accessed on the corporate Web site beginning Wednesday,
January 30, 2008 at approximately 5:00 p.m. PST (8:00 p.m. EST). The replay
will remain available until Accuray announces its results for the third
quarter of fiscal 2008, ending March 31, 2008.
About the CyberKnife(R) Robotic Radiosurgery System
The CyberKnife Robotic Radiosurgery System is the world's only robotic
radiosurgery system designed to treat tumors anywhere in the body
non-invasively. Using continual image guidance technology and computer
controlled robotic mobility, the CyberKnife System automatically tracks,
detects and corrects for tumor and patient movement in real-time throughout
the treatment. This enables the CyberKnife System to deliver high-dose
radiation with pinpoint precision, which minimizes damage to surrounding
healthy tissue and eliminates the need for invasive head or body stabilization
frames.
About Accuray
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a
global leader in the field of radiosurgery dedicated to providing an improved
quality of life and a non-surgical treatment option for those diagnosed with
cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery
System, which extends the benefits of radiosurgery to include extracranial
tumors, including those in the spine, lung, prostate, liver and pancreas. To
date, the CyberKnife System has been used to treat more than 40,000 patients
worldwide and currently more than 100 systems have been installed in leading
hospitals in the Americas, Europe and Asia. For more information, please visit
http://www.accuray.com.
Safe Harbor Statement
The foregoing may contain certain forward-looking statements that involve
risks and uncertainties, including uncertainties associated with the medical
device industry. Except for the historical information contained herein, the
matters set forth in this press release, clinical studies, regulatory review
and approval, and commercialization of products are forward-looking statements
within the meaning of the "safe harbor" provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements speak only as of the
date the statements are made and are based on information available at the
time those statements are made and/or management's good faith belief as of
that time with respect to future events. You should not put undue reliance on
any forward-looking statements. Important factors that could cause actual
performance and results to differ materially from the forward-looking
statements we make include: market acceptance of products; competing products,
the combination of our products with complementary technology; and other risks
detailed from time to time under the heading "Risk Factors" in our report on
Form 10-Q for the quarterly period ended September 29, 2007 and may be updated
from time to time by our other filings with the Securities and Exchange
Commission. The Company's actual results of operations may differ
significantly from those contemplated by such forward-looking statements as a
result of these and other factors. We assume no obligation to update forward-
looking statements to reflect actual performance or results, changes in
assumptions or changes in other factors affecting forward-looking information,
except to the extent required by applicable securities laws.
SOURCE Accuray Incorporated

Investors, Tom Rathjen, Vice President, Investor Relations, +1-408-789-4458,
trathjen@accuray.com, or Media, Stephanie Tomei, Public Relations Manager,
+1-408-789-4234, stomei@accuray.com, both of Accuray Incorporated